David C. Hanley - 29 Feb 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: CHIEF TECHNICAL OPERATIONS
Signature: /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: NUVB
Transactions as of: 29 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2024, 16:40:00 UTC
Previous filing: 02 Mar 2023
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NUVB	Class A Common Stock						12,000	29 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+500,000		$0.000000	500,000	29 Feb 2024	Class A Common Stock	500,000	$1.87	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 3,000 shares acquired on May 19, 2023 and 3,000 shares acquired on November 17, 2023 under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.